RENAL AID: Understanding Kidney Diseases
This study, called RENAL AID, is collecting information from a large group of people with various kidney diseases, including chronic kidney failure, diabetic nephropathy (kidney damage from diabetes), lupus nephritis (kidney inflammation from lupus), and glomerulonephritis (inflammation of the kidney's filtering units). The goal is to understand what causes these diseases to get worse, how people respond to treatments, and to find new ways to identify kidney problems without needing a biopsy. Researchers are looking at how different factors, including a mechanism called RAF, might predict disease progression over up to 10 years. You can join if you are 18 or older and willing to provide consent. Some participants will have had a kidney biopsy, while others may have diabetes and kidney disease without a recent biopsy.
- Study design
- This is an observational study, meaning researchers will collect information without giving any specific treatments. It aims to include 2000 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for changes in disease progression for up to 10 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Alan S Perlman, M.D. · PRINCIPAL_INVESTIGATOR · The Rogosin Institute
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Change in disease progressionUp to 10 years